METHODS: The GI-COVID-19 is a prospective, multicenter, controlled study. Patients with
and without COVID-19 diagnosis were recruited at hospital admission and asked for GI …

A meta‐analysis was performed to identify patients with coronavirus disease 2019 (COVID‐
19) presenting with gastrointestinal (GI) symptoms during the first and second pandemic …

Objective To perform a systematic review and meta-analysis evaluating the prevalence of
gastrointestinal (GI) symptoms and mortality in patients with coronavirus disease 2019 …

The identification of clinical predictors of progression towards severe form is urgently
needed to enable risk stratification and optimize resource allocation in coronavirus disease …

Background COVID‐19 frequently presents with acute gastrointestinal (GI) symptoms, but it
is unclear how common these symptoms are after recovery. The purpose of this study was to …

The month of December 2019 became a critical part of the time of humanity when the first
case of coronavirus disease 2019 (COVID-19) was reported in the Wuhan, Hubei Province …

Background In the post-pandemic era, a wide range of COVID-19 sequelae is of growing
health concern. However, the risks of digestive diseases in long COVID have not been …

Background Gastrointestinal symptoms have been reported in patients with COVID-19.
Several clinical investigations suggested that gastrointestinal symptoms were associated …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent
extrapulmonary manifestation of COVID-19, we investigated intestinal infection with SARS …

Abstract Coronavirus disease 2019 (COVID‐19) is a health emergency worldwide, and
gastrointestinal (GI) symptoms are increasingly reported in COVID‐19 patients. However …